Pennsylvania HB2226: An Act amending Title 40 (Insurance) of the Pennsylvania Consolidated Statutes, providing for prescription drug cost credits in health insurance; and imposing penalties.

What the bill says

An act prohibiting unfair methods of competition and unfair or deceptive acts or practices in the conduct of any trade or commerce, giving the Attorney General and District Attorneys certain powers and duties and providing penalties," further providing for definitions and for unlawful acts or practices and exclusions; and providing for concurrent jurisdiction.

From the introduced text, February 19, 2026:

An act prohibiting unfair methods of competition and unfair or deceptive acts or practices in the conduct of any trade or commerce, giving the Attorney General and District Attorneys certain powers and duties and providing penalties," further providing for definitions and for unlawful acts or practices and exclusions; and providing for concurrent jurisdiction. The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows: Section 1. Sections 2(4) and 3(a) of the act of December 17, 1968 (P.L.1224, No.387), known as the Unfair Trade Practices and Consumer Protection Law, are amended to read: Section 2. Definitions.--As used in this act. * * * (4) "Unfair methods of competition" and "unfair or deceptive acts or practices" mean any one or more of the (ii) Causing likelihood of confusion or of misunderstanding as to the source, sponsorship, approval or certification of goods or services; (iii) Causing likelihood of confusion or of misunderstanding as to affiliation, connection or association with, or certification by, another; (iv) Using deceptive representations or designations of geographic origin in connection with goods or services; (v) Representing that goods or services have sponsorship, approval, characteristics, ingredients, uses, benefits or quantities that they do not have or that a person has a sponsorship, approval, status, affiliation or connection that he does not have; (vi) Representing that goods are original …

Read the full official text

Sponsors

• Emily Kinkead (D, 20) · primary sponsor
• Andrew Kuzma (R, 39)
• Tarik Khan (D, 194)
• Hanbidge, Liz (D, 61)
• Darisha Parker (D, 198)
• Jeanne McNeill (D, 133)
• Benjamin Waxman (D, 182)
• Carol Hill-Evans (D, 95)
• Johanny Cepeda-Freytiz (D, 129)
• Manuel Guzman (D, 127)
• Melissa Cerrato (D, 151)
• Joseph Hohenstein (D, 177)

Latest actions

1. September 8, 2026: Laid on the table, Sept. 8, 2026
2. September 8, 2026: Re-reported as committed, Sept. 8, 2026
3. June 24, 2026: Re-committed to RULES, June 24, 2026
4. June 24, 2026: First consideration, June 24, 2026
5. June 24, 2026: Reported as amended, June 24, 2026
6. February 19, 2026: Referred to INSURANCE, Feb. 19, 2026

Votes

• House Insurance: Report Bill As Amended (June 24, 2026): 14 yea, 12 nay, passed
• House Insurance: Adopt Amendment (June 24, 2026): 14 yea, 12 nay, passed

Common questions

What is HB2226?

HB2226 is a bill in the Pennsylvania Legislature (2025-2026 Regular Session): An Act amending Title 40 (Insurance) of the Pennsylvania Consolidated Statutes, providing for prescription drug cost credits in health insurance; and imposing penalties.

What does HB2226 do?

In its own words: An act prohibiting unfair methods of competition and unfair or deceptive acts or practices in the conduct of any trade or commerce, giving the Attorney General and District Attorneys certain powers and duties and providing penalties," further providing for definitions and for unlawful acts or practices and exclusions; and providing for concurrent jurisdiction.

What is the status of HB2226?

In committee as of September 8, 2026. Latest action: Laid on the table, Sept. 8, 2026 (September 8, 2026).

Who sponsored HB2226?

Emily Kinkead (D, 20), with 11 co-sponsors.

Where is the official record for HB2226?

On the Pennsylvania Legislature website: https://www.palegis.us/legislation/bills/2025/hb2226